TY - JOUR T1 - How does childhood maltreatment influence cardiovascular disease? A sequential causal mediation analysis JF - medRxiv DO - 10.1101/2020.07.21.20158642 SP - 2020.07.21.20158642 AU - Ana G Soares AU - Laura D Howe AU - Jon Heron AU - Gemma Hammerton AU - Janet Rich-Edwards AU - Maria C Magnus AU - Sarah L Halligan AU - Abigail Fraser Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/07/22/2020.07.21.20158642.abstract N2 - Background Childhood maltreatment has been consistently associated with cardiovascular disease (CVD). However, the mechanisms of this relationship are not yet fully understood. We explored the relative contribution of anxiety/depression, smoking, body mass index (BMI) and inflammation (C-reactive protein, CRP) to the association between childhood maltreatment and CVD in men and women aged 40-69 years in the United Kingdom (UK).Methods We used data from 40,596 men and 59,511 women from UK Biobank. To estimate the indirect effects of childhood maltreatment (physical, sexual and emotional abuse, and emotional and physical neglect) on incident CVD via each of the mediators, we applied a sequential mediation approach.Results All forms of maltreatment were associated with increased CVD risk (hazard ratios (HR) ranging from 1.09 to 1.27). Together anxiety/depression, smoking, BMI and CRP mediated 26%-90% of the association between childhood maltreatment and CVD, and the contribution of these mediators differed by type of maltreatment and sex. Anxiety/depression mediated the largest proportion of the association of sexual abuse, emotional abuse and emotional neglect with CVD (accounting for 16%-43% of the total effect), especially in women. In men, BMI contributed the most to the indirect effect of associations of physical abuse and physical neglect with CVD; in women anxiety/depression and BMI had similar contributions.Conclusions These findings add to the understanding of how childhood maltreatment affects CVD risk and identify modifiable mediating factors which could potentially reduce the burden of CVD in people exposed to maltreatment in early life.Competing Interest StatementThe authors have declared no competing interest.Funding StatementALGS, GH, LDH and AF work in a Unit that receives support from the University of Bristol and UK Medical Research Council (MC_UU_00011/6). AF and ALGS are funded by UK Medical Research Council fellowship to AF (MR/M009351/1). GH is funded by a Sir Henry Wellcome Postdoctoral Fellowship (209138/Z/17/Z). LDH is funded by a UK Medical Research Council fellowship (MR/M020894/1). MCM works at the Centre for Fertility and Health supported by the Research Council of Norway through its Centres of Excellence funding scheme, project number 262700.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UK Biobank received ethical approval from the National Health Service National Research Ethics Service (11/ NW/0382).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesUK Biobank is an open access resource, and the data reported in this study are available via application to the UK Biobank. ER -